retatrutide updates Eli Lilly’s Phase 3 data is in on Retatrutide! Here’s what they found Substack Series 3 of 6:

However, unlike approved GLP-1 medication options, Retatrutide remains under clinical investigation

15, 2025 (GLOBE NEWSWIRE) -- Noom, the leading platform for preventive health and longevity, today announced the launch of Proactive Health Microdose GLP-1Rx, a first-of-its-kind program that integrates GLP-1 medications as part of a larger preventive health program

For a full list of possible side effects, and other important safety information, please reference the Mayo Clinics list of Semaglutide side effects

The changes Ive seen have been sustainable and life-changing. After years of failed attempts to lose weight, I finally found something that works

What the clinical trial numbers do not capture is the real-world experience where many patients on various semaglutide doses report sulfur burps that come and go, particularly in the first few weeks and after dose escalations